Indications

• Psoriasis (see Psoriasis, [[Psoriasis]])

---

Pharmacology

• Phosphodiesterase Type 4 Inhibitor (PDE4 Inhibitor) (see Phosphodiesterase Type 4 Inhibitors, [[Phosphodiesterase Type 4 Inhibitors]])
  • Phosphodiesterase Type 4 is the Predominant cAMP-Metabolizing Enzyme Found in Inflammatory/Immune Cells: this explains the anti-inflammatory properties of these agents

Metabolism

• xxx

---

Administration

• xxxx

Dose Adjustment

• Hepatic:
• Renal:

---

Adverse Effects

Other Adverse Effects

• xxx
• xxx
• xxx

---

References

• xxxx